论文部分内容阅读
目的探讨左卡尼汀联合血液透析治疗尿毒症性周围神经病变的临床治疗方法和效果。方法选取2015年2月~2015年7月来我院接受治疗的60例尿毒症性周围神经病变患者的临床资料,随机将其分为观察组和对照组各30例,给予对照组患者采用常规血液透析进行治疗,给予观察组患者采用左卡尼汀联合血液透析进行治疗,比较两组患者的临床治疗效果。结果观察组患者治疗后显效16例,有效13例,总有效率为96.7%,明显好于对照组总有效率的70%,P<0.05。结论左卡尼汀联合血液透析治疗尿毒症性周围神经病变具有良好的效果,值得在临床上推广应用。
Objective To investigate the clinical efficacy and safety of levocarnitine combined with hemodialysis in the treatment of uremic peripheral neuropathy. Methods The clinical data of 60 patients with uremic peripheral neuropathy treated in our hospital from February 2015 to July 2015 were randomly divided into observation group (30 cases) and control group (30 cases), and patients in control group Hemodialysis treatment, the observation group were treated with levocarnitine combined with hemodialysis, the clinical efficacy of the two groups were compared. Results In the observation group, 16 cases were markedly effective and 13 cases were effective. The total effective rate was 96.7%, which was significantly better than 70% of the control group, P <0.05. Conclusion L-carnitine combined with hemodialysis treatment of uremic peripheral neuropathy has a good effect, it is worth in the clinical application.